
    
      The Grand Drug-Eluting Stent (Grand-DES) Registry incorporated five different multicenter
      registries in South Korea. The EXCELLENT prospective cohort and the EXCELLENT-PRIME registry
      were dedicated for durable polymer-coated everolimus-eluting stents (DP-EES; Xience V/Promus
      and Xience Prime) or 1st-generation sirolimus-eluting stents (Cypher), the HOST-RESOLINTE and
      RESOLUTE-Korea registry for durable polymer-coated zotarolimus-eluting stents (DP-ZES;
      Resolute Integrity and Endeavor Resolute) or 1st-generation Endeavor-ZES, and the
      HOST-BIOLIMUS-3000-Korea registry for biodegradable polymer-coated biolimus-eluting stents
      (BP-BES; Biomatrix, Biomatrix Flex, and Nobori). During the period of 2008 through 2014, all
      registries enrolled all-comers without any exclusion criteria except patient's withdrawal of
      consent.
    
  